Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1487970950
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6041 Cadillac Ave
Los Angeles, CA, 90034
Phone (301) 514-7397
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,971
96 services
Medicare patients, 2024
17
Average age 68
Drug cost, 2024
$7.5M
3,154 prescriptions
Company payments, 2025
$865
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michael Y Cho prescribed most often to Medicare patients was Abiraterone Acetate, with 642 prescriptions and refills. In total Michael Y Cho wrote 3,154 Medicare prescriptions that cost $7.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 642 | 651 | 100 | $92K |
| Prednisone Generic | 308 | 824 | 118 | $3,002 |
| Xtandi Enzalutamide | 125 | 125 | 20 | $1.3M |
| Dexamethasone Generic | 113 | 131 | 43 | $1,481 |
| Nivestym Filgrastim-Aafi | 92 | 92 | 38 | $75K |
| Acyclovir Generic | 76 | 167 | 28 | $1,825 |
| Potassium Chloride Generic | 70 | 96 | 29 | $2,032 |
| Hydroxyurea Generic | 69 | 213 | 23 | $3,009 |
| Nubeqa Darolutamide | 69 | 69 | Under 11 | $669K |
| Exemestane Generic | 66 | 199 | 20 | $5,401 |
| Prochlorperazine Maleate Generic | 62 | 62 | 38 | $929 |
| Brukinsa Zanubrutinib | 61 | 61 | Under 11 | $491K |
| Eliquis Apixaban | 59 | 134 | 19 | $76K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 52 | 52 | 14 | $1,325 |
| Granix Tbo-Filgrastim | 50 | 50 | 20 | $25K |
Brand drugs: - claims; generic drugs: 2,249 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Y Cho $865 ($865 in general payments such as food, travel and fees) from 5 companies. The largest payer was Incyte Corporation with $250.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.